Last Updated 24 November 2022.
10 Vaccines Approved for Use in Norway
-
Sanofi/GSK
VidPrevtyn Beta- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 30 countries
3 trials in 2 countries
Approval Source: ema.europa.eu
-
Novavax
Nuvaxovid- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 40 countries
22 trials in 14 countries
Approval Source: ema.europa.eu
-
Moderna
Spikevax- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 88 countries
70 trials in 24 countries
Approval Source: ema.europa.eu
-
Moderna
Spikevax Bivalent Original/Omicron BA.1- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 38 countries
5 trials in 4 countries
Approval Source: ema.europa.eu
-
Moderna
Spikevax Bivalent Original/Omicron BA.4/BA.5- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 33 countries
2 trials in 1 country
Approval Source: ema.europa.eu
-
Pfizer/BioNTech
Comirnaty- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 149 countries
100 trials in 31 countries
Approval Source: ema.europa.eu
-
Pfizer/BioNTech
Comirnaty Bivalent Original/Omicron BA.1- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 35 countries
3 trials in 5 countries
Approval Source: ema.europa.eu
-
Pfizer/BioNTech
Comirnaty Bivalent Original/Omicron BA.4/BA.5- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 33 countries
4 trials in 1 country
Approval Source: ema.europa.eu
-
Janssen (Johnson & Johnson)
Jcovden- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 113 countries
26 trials in 25 countries
Approval Source: ema.europa.eu
-
Valneva
VLA2001- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 33 countries
9 trials in 4 countries
Approval Source: ema.europa.eu
2 Vaccines in Clinical Trials in Norway
-
Nykode Therapeutics
VB10.2129- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Nykode Therapeutics
VB10.2210- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country